Search
Now showing items 1-7 of 7
Molecular landscape of LncRNAs in prostate cancer: A focus on pathways and therapeutic targets for intervention
(PMC, 2022)
Background: One of the most malignant tumors in men is prostate cancer that is still incurable due to its heterog‑
enous and progressive natures. Genetic and epigenetic changes play signifcant roles in its development. ...
Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
(AICHE Online Library, 2022)
Green chemistry has been a growing multidisciplinary field in recent years showing great promise in biomedical applications, especially for cancer therapy. Chitosan (CS) is an abundant biopolymer derived from chitin and ...
Customizing nano-chitosan for sustainable drug delivery
(PMC, 2022)
Chitosan is a natural polymer with acceptable biocompatibility, biodegradability, and mechanical stability; hence, it has been widely appraised for drug and gene delivery applications. However, there has been no comprehensive ...
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
(Elsevier, 2022)
The site-specific delivery of antitumor agents is of importance for providing effective cancer suppression. Poor bioavailability of anticancer compounds and the presence of biological barriers prevent their accumulation ...
Magnetic nanocomposites for biomedical applications
(Elsevier B.V., 2022)
Tissue engineering and regenerative medicine have solved numerous problems related to the repair and regeneration of damaged organs and tissues arising from aging, illnesses, and injuries. Nanotechnology has further aided ...
Advances in aptamer-based drug delivery vehicles for cancer therapy
(Elsevier, 2022)
Overall, aptamers are special classes of nucleic acid-based macromolecules that are beginning to investigate because of their capability of avidity binding to a specific target for clinical use. Taking advantage of ...
Electrically conductive carbon-based (bio)-nanomaterials for cardiac tissue engineering
(John Wiley and Sons Inc, 2022)
A proper self-regenerating capability is lacking in human cardiac tissue which along with the alarming rate of deaths associated with cardiovascular disorders makes tissue engineering critical. Novel approaches are now ...